NCT06482073

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 40 (estimated)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.

Detailed description

PRIMARY OBJECTIVES: I. Assessing whether the percentage of samples adequate for WES (Whole Exome Sequencing)/WT (Wild-Type) sequencing is at least 80%. II. Development of a data bank of WES/WT and germline sequencing data for future analyses. OUTLINE: This is an observational study. Patients receive genomic counseling and genomic testing education, undergo blood or saliva collection, provide previously collected tissue sample and have medical records reviewed on study. Patients and healthcare providers receive results of any genetic variants found on testing.

Conditions

• Lung Carcinoma
• Metastatic Malignant Neoplasm in the Lung

Interventions

Type	Name	Description
OTHER	Non-Interventional Study	Non-interventional study

Timeline

• Start date: 2024-06-24
• Primary completion: 2027-07-01
• Completion: 2027-07-01
• First posted: 2024-07-01
• Last updated: 2026-02-27

Locations

1 site across 1 country: United States